Details for Patent: 8,841,252
✉ Email this page to a colleague
Summary for Patent: 8,841,252
Title: | Pharmaceutical formulation |
Abstract: | The invention relates to aqueous pharmaceutical formulations comprising human growth hormone, histidine, poloxamer, phenol, and mannitol. |
Inventor(s): | Bjorn; Soren (Lyngby, DK), Sorensen; Hans Holmegaard (Virum, DK), Langballe; Peter (Charlottenlund, DK), Larsen; Silke Moller (Charlottenlund, DK), Ebbehoj; Kristen (N.ae butted.rum, DK), Hansen; Birthe Lykkegaard (V.ae butted.rlose, DK) |
Assignee: | Novo Nordisk Health Care AG (Zurich, CH) |
Application Number: | 12/575,886 |
Patent Claim Types: see list of patent claims | Formulation; Compound; |
Drugs Protected by US Patent 8,841,252
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,841,252
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Denmark | 0490/96 | Apr 24, 1996 |
International Family Members for US Patent 8,841,252
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 309819 | ⤷ Try a Trial | |||
Australia | 2634397 | ⤷ Try a Trial | |||
Australia | 733592 | ⤷ Try a Trial | |||
Brazil | 9708858 | ⤷ Try a Trial | |||
Canada | 2252535 | ⤷ Try a Trial | |||
China | 1130223 | ⤷ Try a Trial | |||
China | 1216472 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |